Exciting program at the Acta Oncologica Nordic Precision Cancer Medicine Symposium

‍

The second Nordic Precision Cancer Medicine Symposium (NPCM2025), an Acta Oncologica conference entitled “Merging Clinical Research and Standard Healthcare” takes place at The Hub in Oslo, September 15-17, 2025. The symposium is organized by Oslo University Hospital in collaboration with MATRIX, the Norwegian Centre for Clinical Cancer Research and brings researchers, clinicians and industry representatives together for a 2.5-day event.

The organizing committee is excited to share a fantastic program where fifteen renowned speakers have been invited to share their latest updates in four scientific sessions and three keynote lectures:

‍

Keynotespeakers

Patricia LoRusso, Yale Cancer Center & AACR President

Edwin Cuppen, Hartwig Medical Foundation

Andreas Bjerrum, Copenhagen University Hospital

‍

Scientific Sessions

Precision Diagnostics:

Alona Sosinsky, Genomics England

Janne Lehtiö, Karolinska Institutet

Kushtrim Kryeziu, Oslo University Hospital

‍

Precision Immune Oncology &Functional Precision Oncology:

Diana Azzam, Florida International University

Thorsten Zenz, University Hospital Zurich

Heidi Haikala, University of Helsinki

‍

Precision Cancer Medicine Trials:

Anna Martling, Karolinska Institutet

Ruth Plummer, Newcastle University

Kimmo Porkka, Helsinki University Hospital

‍

Precision Cancer Medicine Implementation:

Christine Leopold, Utrecht Center for Pharmaceutical Policy & Regulation

David Thomson, National Institute for Health & Care Excellence (NICE)

Per-Olof Thuresson, Roche

‍

In addition to the invited speakers, eight speakers have been selected to give short talks based on their submitted abstracts:

·       Gang Chen, University of Melbourne, Australia

·       Bettina Ryll, Vision Zero Cancer, Sweden & the Melanoma Patient Network Europe

·       Sheraz Yaqub, Oslo University Hospital & University of Oslo

·       Oskar Frisell, The Swedish Institutefor Health Economics & Karolinska Institutet

·       Alfonso Urbanucci, Oslo University Hospital & Tampere University

·       Katarina Puco, Oslo University Hospital

·       Bjarne Johannessen, Oslo University Hospital

·       Pilar Ayuda-Durán, Oslo University Hospital

‍

The NPCM2025 conference also offers great networking opportunities during a 2-hour poster session and at the conference banquet dinner as well as at a get-together the first evening.

‍

Don’t miss the opportunity to attend this exciting event and learn more about precision cancer medicine and all the impressive efforts taking place both in Europe and globally!

‍

Late registration is still open until early August (or until we reach our max capacity).

Check out the program details at the NPCM2025 website!

‍